|
1. The Modern Diagnostic Work-Up of Multiple Myeloma and Related Disorders1. The Modern Diagnostic Work-Up of Multiple Myeloma and Related Disorders
|
by
Dr Angela Dispenzieri
Multiple myeloma is a malignant plasma-cell proliferative disorder with an expected 19,920 new cases and 10,690 deaths in the United States in 2008
...
Learn More
|
CME Credits
1.25
AMA PRA
Category 1 Credits™
|
|
|
2. Myeloma Bone Disease: Pathogenesis, Diagnosis, and Treatment2. Myeloma Bone Disease: Pathogenesis, Diagnosis, and Treatment
|
by
Dr James R. Berenson
Patients with multiple myeloma commonly experience skeletal-related complications that are a result of a shift in the normal balance between bone formation
...
Learn More
|
CME Credits
1.00
AMA PRA
Category 1 Credits™
|
|
|
3. Management of Multiple Myeloma: Risk Factors and Treatment Strategies3. Management of Multiple Myeloma: Risk Factors and Treatment Strategies
|
by
Dr Bart Barlogie and Dr Elias Anaissie
The initial evaluation of the patient with symptomatic multiple myeloma (MM) must establish whether the disease is symptomatic, hence requiring therapy
...
Learn More
|
CME Credits
3.00
AMA PRA
Category 1 Credits™
|
|
|
4. Novel Anticancer Agents and Their Clinical Implications4. Novel Anticancer Agents and Their Clinical Implications
|
by
Dr Donna M. Weber
For decades, chemotherapy for multiple myeloma has consisted of standard
combinations of alkylating agents, anthracyclines, and steroids
...
Learn More
|
CME Credits
1.00
AMA PRA
Category 1 Credits™
|
|
|
5. Amyloidosis, POEMS, and Castleman Disease5. Amyloidosis, POEMS, and Castleman Disease
|
by
Dr Raymond L. Comenzo
Amyloidosis represents a group of disorders caused by abnormal folding, aggregation,
and accumulation of certain precursor proteins in the tissues.
...
Learn More
|
CME Credits
1.25
AMA PRA
Category 1 Credits™
|
|
|
6. Waldenström’s Macroglobulinemia6. Waldenström’s Macroglobulinemia
|
by
Dr Steven P. Treon
Waldenström’s macroglobulinemia (WM) is a distinct clinicopathological entity characterized primarily by bone marrow infiltration with clonally related lymphocytes
...
Learn More
|
CME Credits
0.75
AMA PRA
Category 1 Credits™
|
|